AcuCort AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6.68	7.72	6.59	5.02	3.46
Revenue Growth (YoY)	-13.40%	17.07%	31.24%	45.05%	126.68%
Cost of Revenue	20.46	16.11	15.02	-	-
Gross Profit	-13.77	-8.39	-8.43	5.02	3.46
Selling, General & Admin	4.57	5.32	4.82	3.86	2.83
Other Operating Expenses	-	-	-	15.99	11.92
Operating Expenses	12.72	8.99	4.82	19.85	14.76
Operating Income	-26.49	-17.39	-13.25	-14.83	-11.3
Interest Expense	-0.29	-0.16	-0.73	-0.02	-0.03
Interest & Investment Income	0.6	0.15	0.29	0.05	-
Pretax Income	-26.19	-17.4	-13.69	-14.79	-11.32
Net Income	-26.19	-17.4	-13.69	-14.79	-11.32
Net Income to Common	-26.19	-17.4	-13.69	-14.79	-11.32
Shares Outstanding (Basic)	119	83	31	31	20
Shares Outstanding (Diluted)	119	83	31	31	20
Shares Change (YoY)	43.69%	166.25%	-1.11%	61.21%	0.54%
EPS (Basic)	-0.22	-0.21	-0.44	-0.47	-0.58
EPS (Diluted)	-0.22	-0.21	-0.44	-0.47	-0.58
Gross Margin	-206.09%	-108.76%	-127.81%	100.00%	100.00%
Operating Margin	-396.42%	-225.28%	-200.99%	-295.14%	-326.16%
Profit Margin	-391.89%	-225.45%	-207.69%	-294.43%	-326.91%
EBITDA	-18.34	-13.71	-	-	-
EBITDA Margin	-274.47%	-177.67%	-	-	-
D&A For EBITDA	8.15	3.67	-	-	-
EBIT	-26.49	-17.39	-13.25	-14.83	-11.3
EBIT Margin	-	-225.28%	-200.99%	-295.14%	-
Revenue as Reported	6.68	7.72	6.59	5.02	3.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.